Research
Showing of 141 results
Experts from Across the Country Comprise Medical Advisory Board of New University Hospitals Haslam Sports Innovation Center
Accomplished board members will guide the work to develop new technology, reduce injury risk and promote healing for all athletes.
The Oxford-Harrington Rare Disease Centre Announces Newly Funded Grant Award Programs to Develop New Therapies for Friedreich’s Ataxia
Philanthropic donation of up to £650,000 (approx. $823,000 USD) will enable the launch of two new grant award programs to support the research and development of greatly needed therapeutics for Friedreich’s Ataxia (FA).
University Hospitals joins CWRU in Development of "live" Replacement Joints with Backing of Federal Grant
The goal is life-changing treatment for osteoarthritis — the most common degenerative joint disease affecting 500 million people worldwide.
Harrington Discovery Institute Announces 2024 Scholar-Innovator Award Recipients
Ten physician-scientists have been selected for drug development grant to advance discoveries into the clinic.
Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute Center for Brain Health Medicines Invite Proposals for 2024 ADDF-Harrington Scholar Award
Call for proposals focused on proteostasis, senescence, and other novel approaches.
University Hospitals Physician-scientist, Linda Cummings, Selected for American Gastroenterological Association Pilot Research Award
Research will address growing problem of antimicrobial resistance in eradicating Helicobacter Pylori (H. pylori), a bacterial infection that increases the risk of gastric cancer and peptic ulcer disease.
Case Western Reserve University and University Hospitals' Researchers Report Rise in Global Fungal Drug-resistant Infections
Researchers issue call to action to address and prevent growing problem.
Oxford-Harrington Rare Disease Centre to Hold Webinar Entitled Pioneering a Path to Rare Disease Therapeutics
OHC’s 4th Rare Disease Day webinar to be held on Feb. 28, 2024 at 10 a.m. ET 3 p.m. GMT.